NAVLE Microbiology: High-Yield Bacteria and Fungi

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Bacillus anthracis is characterized by peracute death in ruminants and horses, with diagnosis confirmed by blood smear due to the risk of environmental spore contamination during necropsy; it is a notifiable disease.
• Neurotoxic Clostridium species, C. tetani (rigid paralysis) and C. botulinum (flaccid paralysis), are diagnosed clinically and via toxin detection in serum or feed, requiring prompt antitoxin administration.
• Brucella canis in dogs presents with discospondylitis and reproductive issues, diagnosed by blood culture or serology, and carries zoonotic risk, necessitating careful handling and owner education.
• Rhodococcus equi causes pyogranulomatous pneumonia in foals, with diagnosis confirmed by tracheal wash cytology and culture, and requires intracellular-penetrating antimicrobials.
• Systemic fungal infections like Blastomyces dermatitidis and Cryptococcus neoformans are diagnosed via cytology, urine antigen testing (for Blastomyces), or latex agglutination antigen tests, often presenting with respiratory, cutaneous, or neurological signs.
• Gram-negative sepsis syndromes caused by E. coli, Salmonella, and Klebsiella pneumoniae necessitate blood, fecal, or urine culture with susceptibility testing due to the prevalence of multidrug-resistant strains.

This article organizes the bacterial and fungal pathogens most frequently tested on the NAVLE into a framework built on transmission, pathogenesis, diagnostic sampling, and species-specific disease expression. It serves veterinary students who have completed their core microbiology coursework and now need a consolidated review that prioritizes exam-relevant distinctions over exhaustive taxonomy. The content answers a specific question: which organizms, clinical presentations, and diagnostic decisions merit the greatest share of your remaining study time.

The NAVLE distributes questions across content areas defined by the International Council for Veterinary Assessment, and microbiology appears within the organ-system and species-based domains instead of as a standalone discipline. That means you must recognize an organizm from its clinical syndrome, not from a list. The approach here mirrors that structure. Each pathogen is presented with its defining host range, the lesion pattern it produces, the sample type that yields a diagnosis, and the differential diagnoses that most often create confusion. The ICVA NAVLE candidate information describes the examination structure and content distribution that informs this prioritization.

At a Glance

Bacterial Pathogens by Transmission Route

Soil-Associated and Environmental Bacteria

Bacillus anthracis occupies a unique position in veterinary microbiology because its spores persist in soil for decades and its clinical presentation is among the most acute in large animal medicine. Ruminants are most susceptible, with peracute death and unclotted blood escaping from natural orifices. The organizm forms characteriztic boxcar-shaped gram-positive rods in chains, and a blood smear from a peripheral vein is the diagnostic sample of choice. Necropsy is contraindicated because exposure of spores to oxygen triggers sporulation and contaminates the environment. The WOAH terrestrial animal health standards classify anthrax as a notifiable disease and define surveillance and control expectations for member countries.

Clostridium tetani and Clostridium botulinum produce the two classic neurotoxicity syndromes that appear repeatedly on the NAVLE. Tetanus presents with extensor rigidity, elevated tail head, and prolapsed nictitans in horses and sheep. The diagnosis is clinical, supported by a history of a penetrating wound, though the wound may be inapparent. Botulism presents with the opposite picture: flaccid paralysis, dysphagia, and a weak tongue. In cattle, the source is often contaminated feed or water, while in horses it may be spoiled silage or wound colonization. Toxin detection in serum, feed, or intestinal contents confirms the diagnosis, but treatment must begin before results return. Both diseases require antitoxin administration and supportive care, and the MSD Veterinary Manual provides species-specific management guidance that differs meaningfully between horses, ruminants, and companion animals.

Zoonotic and Reportable Pathogens

Brucella species appear across multiple NAVLE content areas because their zoonotic potential and reportable status shape clinical decision-making. Brucella canis causes discospondylitis, orchitis, epididymitis, and late-term abortion in dogs. Diagnosis relies on blood culture during the bacteremic phase or serology, with the agar gel immunodiffusion test offering better specificity than the rapid slide agglutination test. Brucella abortus and B. melitensis affect cattle and small ruminants respectively, causing abortion storms and retained placenta. These species are reportable in most jurisdictions, and the AVMA practice resources outline the professional obligations that apply when a zoonotic agent is suspected. The key exam distinction is that B. canis is not regulated to the same degree as the ruminant species, but it still carries zoonotic risk, particularly for immunocompromised owners.

Mycobacterium bovis produces chronic granulomatous lesions primarily in the respiratory tract of cattle, with spread to lymph nodes, and can infect deer, wildlife, and humans. The tuberculin skin test using purified protein derivative remains the standard screening tool in cattle, with confirmatory culture and PCR on tissue samples. The WOAH terrestrial animal health standards define the tuberculin test protocols and interpretation criteria that are recognized internationally. The critical differential is Mycobacterium avium subsp. paratuberculosis, which causes Johne's disease with granulomatous enteritis and chronic diarrhea instead of respiratory disease. These two mycobacteria are frequently confused on exams because both produce granulomas and both are slow-growing, but their clinical presentations and sample types are entirely distinct.

Gram-Positive Cocci and Rods

Rhodococcus equi and the Foal Pneumonia Complex

Rhodococcus equi is a soil-borne, facultative intracellular gram-positive pleomorphic rod that causes pyogranulomatous pneumonia in foals between one and four months of age. The organizm survives within macrophages by preventing phagolysosomal fusion, which explains the characteriztic abscess formation and the need for combination antimicrobial therapy that penetrates intracellular compartments. Clinical signs include fever, tachypnea, and cough, with thoracic radiographs revealing a caudodorsal alveolar pattern and tracheobronchial lymphadenopathy. Tracheal wash cytology and culture provide the definitive diagnosis, and the MSD Veterinary Manual describes the ultrasonographic findings that help assess abscess progression. The primary differential is Streptococcus equi subsp. zooepidemicus, which also causes pneumonia in foals but tends to produce a more acute, exudative picture without the same intracellular persistence.

Streptococcus and Staphylococcus Species

The beta-hemolytic streptococci are tested through their species-specific syndromes. Streptococcus equi subsp. equi causes strangles in horses, characterized by fever, mucopurulent nasal discharge, and abscessation of the submandibular and retropharyngeal lymph nodes. Diagnosis is by culture or PCR of nasal swabs or abscess contents. Streptococcus canis causes toxic shock syndrome and necrotizing fasciitis in dogs, often following minor wounds. Staphylococcus pseudintermedius is the most common cause of canine pyoderma and otitis externa, and its methicillin-resistant strains are a recurring NAVLE topic because they alter antimicrobial selection and infection control protocols. The AVMA practice resources address antimicrobial stewardship expectations that apply when resistant organizms are identified. The exam distinction that matters most is between coagulase-positive staphylococci, which are pathogenic, and coagulase-negative species, which are usually contaminants.

Gram-Negative Bacteria

Enterobacteriaceae and the Sepsis Syndromes

Escherichia coli, Salmonella species, and Klebsiella pneumoniae account for a substantial portion of gram-negative sepsis questions. E. coli is the leading cause of neonatal septicemia in foals and calves, presenting with fever, depression, and diarrhea, and it is also the most common cause of urinary tract infections in dogs. Salmonella species cause acute enteritis with fever and septicemia in multiple species, and the carrier state in cattle and horses creates persistent herd-level challenges. Klebsiella pneumoniae causes metritis in mares and nosocomial infections in hospitalized patients. The unifying diagnostic principle is that blood culture, fecal culture, or urine culture with antimicrobial susceptibility testing is required because empiric therapy is unreliable given the prevalence of multidrug-resistant strains. The MSD Veterinary Manual provides the species-specific clinical presentations and treatment frameworks that distinguish these organizms on exams.

Pasteurella, Mannheimia, and Respiratory Pathogens

Mannheimia hemolytica and Pasteurella multocida are the primary bacterial agents in bovine respiratory disease complex and porcine respiratory disease respectively. M. hemolytica produces fibrinous bronchopneumonia in cattle, often following viral infection or transport stress, with the characteriztic "oat cell" appearance on histopathology. P. multocida causes atrophic rhinitis in pigs when co-infected with toxigenic strains, and it also causes fowl cholera in poultry. The exam emphasis is on the pathogenesis: these organizms are commensals of the upper respiratory tract that cause disease when host defenses are compromised. Deep nasal swabs, transtracheal washes, or lung tissue at necropsy are the appropriate samples, and culture results must be interpreted in the context of the commensal flora that will also grow.

Anaerobic Bacteria

Fusobacterium and Bacteroides

Fusobacterium necrophorum causes hepatic abscessation in feedlot cattle, foot rot in cattle and sheep,

Diagnostic Workup and Sample Selection

The diagnostic sequence for suspected bacterial or fungal disease begins with sample selection, which determines every downstream test's reliability. For superficial pyoderma, collect intact pustules with a sterile needle and syringe, not surface swabs, which recover commensal flora. For deep pyoderma or furunculosis, biopsy tissue from the active margin and submit separate samples for histopathology and culture. Aspirates of abscesses should be obtained through intact skin after surgical preparation, and anaerobic transport medium is required for suspected anaerobes such as Fusobacterium or Bacteroides.

Respiratory samples follow a hierarchy of diagnostic value. Transtracheal wash or bronchoalveolar lavage outperforms nasal swabs for lower airway disease because nasal flora contaminates proximal samples. For foals with suspected Rhodococcus equi, tracheobronchial aspirate culture paired with quantitative PCR provides the strongest antemortem confirmation, though serial thoracic ultrasonography for abscess detection remains the primary screening tool. Urine culture requires cystocentesis in most species, free-catch samples are acceptable only for screening and must be interpreted with quantitative thresholds.

Fungal diagnostics differ by organizm class. Dermatophytes are confirmed by fungal culture on dermatophyte test medium, which contains a pH indicator that turns red with pathogenic species, or by direct microscopic examination of plucked hairs in potassium hydroxide. Systemic mycoses such as Blastomyces or Histoplasma are best detected by cytology of affected tissue, urine antigen testing for blastomycosis, or serology where validated. Cryptococcus is identified by cytology showing narrow-based budding yeasts with thick capsules, and capsular antigen testing on serum or cerebrospinal fluid supports the diagnosis.

Culture Interpretation and Susceptibility Testing

Culture results require interpretation in clinical context, not reflexive treatment. Growth of Escherichia coli from a cystocentesis sample is significant at any colony count, whereas the same organizm from a free-catch sample may represent contamination. Mixed growth from a surface swab rarely justifies antimicrobial therapy. For Staphylococcus pseudintermedius, the dominant canine pyoderma pathogen, culture and susceptibility testing is indicated for recurrent infections, methicillin resistance, or when first-line therapy fails.

Susceptibility testing should follow Clinical and Laboratory Standards Institute methods, and results must be read with species-specific breakpoints where they exist. Methicillin-resistant staphylococci are detected by oxacillin or cefoxitin disk testing, and resistance extends to all beta-lactams regardless of in vitro results. For gram-negative sepsis syndromes, request minimum inhibitory concentration values instead of qualitative susceptible-intermediate-resistant categories, because dose-dependent susceptibility may permit high-dose therapy for organizms with intermediate MICs.

Fungal susceptibility testing is reserved for specific scenarios: refractory dermatophytosis, systemic mycoses failing standard therapy, or infections in immunocompromised patients. Routine susceptibility testing of dermatophytes is not indicated because wild-type isolates are predictably susceptible to licensed topical and systemic agents. The MSD Veterinary Manual provides species-specific guidance on when susceptibility testing changes therapeutic decisions and when it adds cost without clinical benefit MSD Veterinary Manual professional reference.

Antimicrobial Selection Frameworks

Antimicrobial choice follows a hierarchy: identify the pathogen, determine the infection site, assess host factors, then select the narrowest effective agent. For gram-positive cocci in skin and soft tissue, first-generation cephalosporins or penicillinase-resistant penicillins remain appropriate first-line choices where resistance patterns permit. For gram-negative enteric infections, fluoroquinolones or third-generation cephalosporins are reserved for confirmed susceptibility or critical illness, because overuse drives extended-spectrum beta-lactamase production.

The decision to use a bactericidal versus bacteriostatic agent depends on infection site and host status. Bactericidal drugs are preferred for endocarditis, meningitis, osteomyelitis, and neutropenic patients. Bacteriostatic agents such as tetracyclines or macrolides are acceptable for immunocompetent patients with superficial infections, but they should not be used for life-threatening sepsis. For Rhodococcus equi, macrolide-rifampin combinations remain standard, though rifampin resistance emerges with monotherapy, and newer macrolide formulations offer once-daily dosing.

Duration of therapy varies by syndrome. Uncomplicated cystitis requires 3 to 7 days in dogs and cats. Pyelonephritis requires 2 to 4 weeks. Osteomyelitis and endocarditis require 4 to 8 weeks or longer, with clinical response and serial biomarkers guiding cessation. Fungal infections require the longest courses: dermatophytosis is treated until two consecutive negative cultures are obtained, and systemic mycoses are treated for months with radiographic and serologic monitoring.

Monitoring Parameters and Treatment Failure

Monitoring serves two purposes: confirming therapeutic response and detecting adverse effects. For bacterial infections, resolution of fever, improved appetite, and normalization of inflammatory markers such as C-reactive protein or serum amyloid A indicate response. For deep infections, repeat imaging documents resolution of abscesses or osteomyelitis. For fungal disease, serial antigen titers, where validated, track organizm burden and guide treatment duration.

Treatment failure demands a structured reassessment. First, confirm the diagnosis was correct. Second, verify owner compliance and drug administration. Third, repeat culture to detect acquired resistance. Fourth, consider sequestered infection, foreign body, or biofilm. For Staphylococcus biofilms on implants, antimicrobial therapy alone rarely resolves infection, and device removal is often required. For fungal infections failing azole therapy, measure serum drug concentrations where assays exist, because interindividual pharmacokinetic variability is substantial.

Nephrotoxicity from aminoglycosides and ototoxicity from aminoglycosides or fluoroquinolones require baseline and serial monitoring. Hepatotoxicity from azole antifungals warrants periodic liver enzyme assessment. The AVMA practice resources outline responsible antimicrobial stewardship principles, including using targeted therapy, avoiding prophylactic use in clean surgery, and discontinuing therapy when infection is ruled out AVMA professional practice resources.

Documentation and Reporting

Clinical records must document the diagnostic rationale, sample type, culture results with quantitative significance, susceptibility interpretation, and the antimicrobial plan with expected duration and recheck interval. For reportable diseases, notification obligations vary by jurisdiction, and the World Organization for Animal Health terrestrial animal health standards define international reporting requirements for listed diseases WOAH terrestrial animal health standards. Clinicians should confirm local reporting requirements before initiating treatment for suspected zoonotic or production-limiting pathogens.

Laboratory reports should be reviewed for completeness: organizm identification, colony count or semiquantitative growth, susceptibility results with interpretive criteria, and any comments on mixed flora. Discrepancies between cytology and culture, such as organizms seen on cytology but not growing in culture, suggest fastidious organizms, prior antimicrobial exposure, or anaerobic infection, and should prompt discussion with the laboratory.

Comparative Diagnostic Features Table

Sample selection changes with patient status. Immunocompromised patients may have disseminated disease requiring blood culture and bone marrow evaluation. Foals with suspected Rhodococcus should have thoracic ultrasound before respiratory sampling to guide sample site selection. Production animals with suspected reportable disease should be sampled with biosecurity precautions, and samples should be submitted to laboratories equipped for high-consequence pathogens.

Recognized Failure Modes and Early Detection

The most consequential failure in veterinary microbiology is the misinterpretation of a contaminant as a pathogen. Coagulase-negative staphylococci, Bacillus species, and diphtheroids recovered from skin or mucosal sites rarely explain systemic disease. Detection begins at collection. A sample obtained through an infected site, after antimicrobial therapy has begun, or after prolonged storage at room temperature will produce misleading results. Compare the Gram stain morphology with the culture isolate. If the stained specimen shows a pure population of one organizm but the culture yields three or more colony types, the additional isolates are likely contaminants or colonisers.

Treatment failure follows a predictable set of patterns. Clinical deterioration despite appropriate antimicrobial selection suggests an undrained abscess, a foreign body, or a biofilm-associated infection. Staphylococcus pseudintermedius and Pseudomonas aeruginosa form biofilms on implanted devices and within chronic wounds. Suspected antimicrobial resistance requires confirmation by repeat culture and susceptibility testing, not empirical escalation. A second pattern is the misidentification of a mixed infection as monomicrobial. Anaerobic bacteria fail to grow if transport media are not used or if cultures are held in ambient oxygen for more than 30 minutes. If a Gram stain shows mixed morphology but aerobic culture yields only one organizm, request anaerobic culture and consider Mycoplasma or Listeria culture on selective media.

Early detection of zoonotic risk depends on recognizing the clinical syndromes that mandate heightened precautions. Brucella canis infection in dogs presents with discospondylitis, orchitis, or abortion. Leptospira infection presents with acute renal injury, hepatic dysfunction, or uveitis. In both cases, the laboratory must be notified before samples are submitted so that appropriate biocontainment protocols are followed. The ICVA NAVLE candidate information lists zoonotic disease recognition among the core clinical competencies examined, and the MSD Veterinary Manual provides species-specific guidance on sample handling and laboratory notification for each notifiable agent.

Common Errors and Corrective Action

Students and early-career clinicians most often err by treating the culture report instead of the patient. A susceptibility result applies to the isolate tested under standardized conditions, not to the infection in situ. Abscess pH, biofilm formation, and host immune status alter drug efficacy in ways the laboratory cannot model. The corrective action is to integrate culture results with cytology, histopathology, and clinical progression before changing therapy.

A second common error is the overinterpretation of a single positive culture for organizms that colonise healthy animals. Bordetella bronchiseptica can be cultured from the upper airways of clinically normal dogs. Malassezia pachydermatis is part of the normal cutaneous flora. Diagnosis requires compatible clinical signs and, where possible, cytologic evidence of organizm-associated inflammation. A third error is the failure to request susceptibility testing for organizms with predictable resistance patterns. Pseudomonas aeruginosa and Enterococcus species require testing because resistance is common and often multidrug. Streptococcus species and Pasteurella species can usually be managed with first-line agents without testing, unless the patient has recent antimicrobial exposure.

The final common error is the omission of anaerobic culture in wounds with devitalised tissue, penetrating injuries, or foul odour. Aerobic culture alone will miss Clostridium, Fusobacterium, and Bacteroides. The corrective action is to submit a second sample in anaerobic transport medium and to communicate the clinical suspicion to the laboratory.

Limitations of the Evidence and Areas of Expert Disagreement

The evidence base for veterinary antimicrobial therapy is thinner than in human medicine. Many recommended regimens derive from small case series, extrapolation from other species, or expert opinion instead of randomised controlled trials. Susceptibility breakpoints are often adapted from human laboratory standards and may not reflect clinical efficacy in veterinary patients. The AAVMC veterinary education resources emphasize the need for graduates to recognize the limits of extrapolated data and to consult current formularies and susceptibility databases.

Expert opinion differs on several practical points. The role of topical therapy in place of systemic antimicrobials for superficial pyoderma remains debated. Some specialists advocate topical chlorhexidine as first-line treatment for canine superficial pyoderma, reserving systemic agents for deep or recurrent disease. Others recommend systemic therapy from the outset. The duration of therapy for chronic osteomyelitis is similarly contested, with recommendations ranging from four to twelve weeks. There is no consensus on the optimal method for monitoring response, although serial radiography and C-reactive protein measurement are used in some referral centers. The AVMA practice resources provide guidance on antimicrobial stewardship frameworks that acknowledge these areas of uncertainty.

Referral, Consultation, and Regulatory Reporting

Referral to a specialist is indicated when infection fails to respond to two appropriate antimicrobial courses, when the causative organizm cannot be identified despite thorough sampling, or when surgical intervention is required for source control. Orthopedic infections, deep fungal infections, and infections in immunocompromised patients warrant early specialist involvement. Laboratory consultation is appropriate when culture results conflict with cytology, when unusual organizms are isolated, or when susceptibility testing shows resistance to all routinely tested agents. Reference laboratories can perform minimum inhibitory concentration testing against a broader panel, synergy testing, and molecular identification.

Regulatory reporting obligations vary by jurisdiction and by agent. WOAH terrestrial animal health standards list notifiable diseases that member countries must report, including anthrax, brucellosis, and glanders. National and regional authorities maintain their own lists, and veterinarians must confirm the requirements for their location. Reportable zoonoses such as rabies, brucellosis, and tuberculosis require immediate notification even when the clinical presentation is atypical. When in doubt, contact the relevant animal health authority before disposal of samples or carcasses.

Troubleshooting Guide

Frequently Asked Questions

How do I prioritize bacterial and fungal topics when my study time is limited?

Focus on agents that appear across multiple body systems and species. The NAVLE content outline, published by the International Council for Veterinary Assessment, distributes questions across clinical disciplines, so organizms with broad clinical relevance, such as Staphylococcus, Escherichia coli, and Malassezia, appear more frequently than rare or region-specific pathogens. Allocate study time proportionally: master the diagnostic approach and treatment framework for common agents first, then learn distinguishing features of less common organizms. For zoonotic and reportable diseases, know the reporting pathway even if clinical recognition is straightforward. Practice with image-based questions on cytology and histopathology, since these appear consistently and reward pattern recognition over memorised facts.

What should I do when anaerobic culture is unavailable or impractical?

Anaerobic culture requires specialised transport media and laboratory capability that many practices lack. When culture is unavailable, use Gram stain and cytology to support a presumptive anaerobic infection. The MSD Veterinary Manual describes characteriztic findings such as mixed bacterial populations, pleomorphic Gram-negative rods, and foul-smelling exudate. Collect samples before antimicrobial therapy and place them in anaerobic transport medium if available. If transport is delayed, inoculation of blood culture bottles can preserve anaerobes for up to 24 hours. Treat empirically based on the suspected source, since anaerobes from oral, gastrointestinal, and urogenital origins have predictable susceptibility patterns. Document the presumptive diagnosis and the rationale for empirical therapy in the medical record.

How does the diagnostic approach differ in exotic pets and wildlife compared with dogs and cats?

Sample volume and handling constraints dominate the differences. Small mammals, birds, and reptiles yield limited blood and tissue samples, so prioritize tests with the highest diagnostic yield. Cytology and Gram stain often provide immediate information before culture results return. Species-specific normal flora differ substantially, so interpret culture results against published reference ranges for that species instead of extrapolating from canine or feline data. The AVMA practice resources note that zoonotic risk assessment changes with exotic species, particularly for agents like Chlamydia psittaci in birds and Mycobacterium species in reptiles. Antimicrobial choices may be constrained by species-specific toxicity, so consult current exotic animal formularies before prescribing.

What records must I keep for bacterial and fungal cases, and for how long?

Maintain complete medical records including signalment, history, physical examination findings, sample collection dates and sites, laboratory results, antimicrobial selection with dose and duration, and outcome. For reportable diseases, retain documentation of the regulatory notification, including the date, method, and agency contacted. The WOAH terrestrial animal health standards describe international reporting obligations for listed diseases, and national authorities may impose additional requirements. Record antimicrobial use with sufficient detail to support stewardship audits and to reconstruct treatment decisions if complications arise. Retention periods vary by jurisdiction, but keeping records for at least the duration of the animal's life plus several years is prudent. For zoonotic cases, document client education about transmission risks.

How do I explain a resistant infection to a client without undermining their confidence?

Use clear, non-technical language that focuses on the treatment plan instead of the laboratory details. Explain that the bacteria causing the infection are not killed by the first-choice medication, and that a different drug, based on culture results, is needed. Avoid blaming previous treatment or the client, since this creates defensiveness and erodes trust. Frame the situation as a common occurrence that the practice manages regularly. The AVMA practice resources emphasize transparent communication about treatment costs and expected duration. Provide written instructions for medication administration and follow-up appointments. Acknowledge that some resistant infections require prolonged therapy or additional diagnostics, and discuss the financial implications openly so the client can make informed decisions.

When should I refer a case or seek consultation for a bacterial or fungal infection?

Refer when the infection involves a site where surgical expertise exceeds your comfort level, such as deep orbital, spinal, or intracranial infections. Seek consultation when susceptibility testing shows resistance to all practical oral options, when the infection recurs despite appropriate therapy, or when the diagnosis remains uncertain after initial testing. Fungal infections with systemic involvement, such as disseminated aspergillosis or cryptococcosis, often benefit from specialist input because treatment is prolonged and monitoring is intensive. The International Council for Veterinary Assessment candidate information describes the clinical reasoning skills expected of a general practitioner, and recognizing your own limits is part of that competency. Document the reason for referral, the information provided to the specialist, and the recommendations received.

Related Clinical & Scientific Guides

• Developing a Study Schedule for NAVLE Diagnostic Reasoning
• Veterinary Physiology Concepts Frequently Tested on the NAVLE
• NAVLE Clinical Rotation Preparation: What to Review Before Each Service

References and Further Reading

• ICVA NAVLE Candidate Information. ICVA.
• AAVMC Veterinary Education Resources. AAVMC.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.
• WOAH Terrestrial Animal Health Code. WOAH.

Related Articles

• Veterinary Microbiology High-Yield Topics for the NAVLE
• High-Yield Anatomy Review for the NAVLE: Canine and Feline Focus
• NAVLE Dermatology: High-Yield Skin Conditions and Diagnostics
• Veterinary Anatomy High-Yield Topics for the NAVLE
• Veterinary Parasitology for the NAVLE: High-Yield Parasites

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.